Skip to content
Episode 49: BIMO Listings episode artwork

Jun 5, 2026 10 min

Episode 49: BIMO Listings

from QCast: Data-Driven Dialogue in Drug Development Hosted by Quanticate

In this QCast episode, Jullia and Tom discuss BIMO listings and their role in FDA inspection readiness. They explain how Bioresearch Monitoring looks at clinical trial conduct, participant protection, data credibility, and the records that support regulatory submissions. The episode also covers common misconceptions, including the idea that BIMO is only a site-level concern, and shows how sponsors can use inspection findings to strengthen oversight before issues become harder to resolve. Key Takeaways BIMO oversight looks beyond final datasets. It considers how data was collected, reviewed, documented, and supported by source records. BIMO listings can highlight patterns around protocol deviations, informed consent, adverse event reporting, data management, and submission readiness. Good preparation depends on timely data entry, clear query handling, documented decisions, version control, and records that can be retrieved and explained. 🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial. 📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast. 🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: Clinical Data Capture & Management Biostatistics & Statistical Consultancy Statistical Programming & PK/PD Analysis Medical Writing & Pharmacovigilance Regulatory & Submission Support AI & Automation Post-Marketing Safety & Real-World Data Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

Episode details come from the podcast's RSS feed.

Embed this episode

In this QCast episode, Jullia and Tom discuss BIMO listings and their role in FDA inspection readiness. They explain how Bioresearch Monitoring looks at clinical trial conduct, participant protection, data credibility, and the records that support regulatory submissions. The episode also covers common misconceptions, including the idea that BIMO is only a site-level concern, and shows how sponsors can use inspection findings to strengthen oversight before issues become harder to resolve. Key ...

Ready to play

Episode 49: BIMO Listings

0:00 10:43

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of QCast: Data-Driven Dialogue in Drug Development?

This episode is 10 minutes long.

When was this QCast: Data-Driven Dialogue in Drug Development episode published?

This episode was published on June 5, 2026.

Can I download this QCast: Data-Driven Dialogue in Drug Development episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.